Patient's perception of exacerbations of COPD - the PERCEIVE study

被引:92
|
作者
Miravitlles, Marc [1 ]
Anzueto, Antonio
Legnani, Delfino
Forstmeier, Leonhard
Fargel, Matthias
机构
[1] Hosp Clin Barcelona, Inst Clin Torax IDIBAPS, Serv Pneumol, Barcelona, Spain
[2] Univ Texas, Hlth Sci Ctr, San Antonio, TX 78285 USA
[3] S Texas Vet Hlth Care Syst, San Antonio, TX USA
[4] Univ Milan, Inst Resp Dis, Milan, Italy
[5] Bayer HealthCare, Wuppertal, Germany
[6] Psyma Int Med Mkt Res GmbH, Rueckersdorf Nuernberg, Germany
关键词
COPD; chronic bronchitis; patient-reported outcomes; respiratory symptoms;
D O I
10.1016/j.rmed.2006.07.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The evaluation of therapies requires the development of patient-reported outcomes (PROs) that help clinicians to understanding the symptoms, perceptions and feelings of patients with exacerbations of chronic obstructive pulmonary disease (COPD). With the aim of obtaining information on the perceptions of patients with COPD, their exacerbations and expectations of treatment, a random telephone contact survey in six countries was performed. From 83,592 households screened, 1100 subjects with symptoms compatible with COPD were identified. The most frequent symptom was shortness of breath (78%). The most frequent complaint was that due to their COPD: "they could not complete the activities they like to do" (54%); 17% (187) of individuals were afraid that their COPD would cripple, or eventually kill them. Exacerbations generated a mean of 5.1 medical visits/year (SD=4.6) with the mean duration of exacerbation symptoms being 10.5 days. Increased coughing was the exacerbation symptom having the strongest impact on well-being (42%). Fifty-five percent of patients declared that quicker symptom relief was the most desired requirement for treatment. New data are provided on the impact of COPD and its exacerbations on the daily life of patients. These data will help to develop PROs designed to evaluate the effectiveness of different therapies for exacerbated COPD. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:453 / 460
页数:8
相关论文
共 50 条
  • [31] Patient perception of Breezhaler® and Ellipta® device feedback mechanisms in COPD: The ADVANTAGE Study
    Altman, Pablo
    Bergna, Miguel A.
    Garcia, Gabriel R.
    Guerin, Tadhg
    Pino, Andrea, V
    Whiteford, John L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (02) : 221 - 227
  • [32] Astegolimab and COPD exacerbations
    不详
    LANCET RESPIRATORY MEDICINE, 2021, 9 (11): : E107 - E107
  • [33] NATURE OF EXACERBATIONS OF COPD
    ANTHONISEN, NR
    MANFREDA, J
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1986, 9 (03): : A154 - A154
  • [34] Hyperinflation in COPD exacerbations
    van Geffen, Wouter H.
    Slebos, Dirk-Jan
    Kerstjens, Huib A. M.
    LANCET RESPIRATORY MEDICINE, 2015, 3 (12): : E43 - E44
  • [35] Infective exacerbations of COPD
    Sayiner, A
    Okyay, N
    Unsal, I
    Colpan, N
    CHEST, 1999, 115 (05) : 1481 - 1481
  • [36] Acute exacerbations of COPD
    MacNee, W
    SWISS MEDICAL WEEKLY, 2003, 133 (17-18) : 247 - +
  • [37] The Out-Patient Daccord Cohort: Frequency Of COPD Exacerbations In Germany
    Kardos, P.
    Buhl, R.
    Criee, C. -P.
    Vogelmeier, C. F.
    Worth, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [38] Antibiotics for exacerbations of COPD
    Ebell, Mark H.
    AMERICAN FAMILY PHYSICIAN, 2006, 74 (05) : 749 - 750
  • [39] Acute COPD Exacerbations
    Wedzicha, Jadwiga A.
    Singh, Richa
    Mackay, Alex J.
    CLINICS IN CHEST MEDICINE, 2014, 35 (01) : 157 - +
  • [40] Smoking and COPD exacerbations
    Badaran, Elena
    Ortega, Ezequiel
    Bujalance, Carlos
    Del Puerto, Lola
    Torres, Mirian
    Antonio Riesco, Juan
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40